To investigate how HDACis affected PMCA expression in melanoma cells, we treated one BRAF wild-type (MEWO) and two BRAF-mutant (A375, A2058) cell lines either with increasing concentrations of SAHA or valproate (Figure 1A) or for different time intervals (Figure 1B). This evidence concerns the gene BRAF and melanoma.